PDF herunterladen
Am J Perinatol 2022; 39(S 01): S49-S51
DOI: 10.1055/s-0042-1757350
Original Article

Rethinking Pulse Oximetry Screening in the Level-IV Neonatal Intensive Care Unit

Bryanna N. Schwartz 
1   Division of Cardiology, Children's National Heart Institute, Children's National Hospital, Washington, District of Columbia
2   Department of Pediatrics, The George Washington University School of Medicine & Health Sciences, Washington, District of Columbia
,
Lisa A. Hom
1   Division of Cardiology, Children's National Heart Institute, Children's National Hospital, Washington, District of Columbia
2   Department of Pediatrics, The George Washington University School of Medicine & Health Sciences, Washington, District of Columbia
,
Mary E. Revenis
2   Department of Pediatrics, The George Washington University School of Medicine & Health Sciences, Washington, District of Columbia
3   Division of Neonatology, Children's National Hospital, Washington, District of Columbia
,
Gerard R. Martin
1   Division of Cardiology, Children's National Heart Institute, Children's National Hospital, Washington, District of Columbia
2   Department of Pediatrics, The George Washington University School of Medicine & Health Sciences, Washington, District of Columbia
› Institutsangaben Funding This work was supported by C.R. Beyda Professorship.
› Weitere Informationen
Auch verfügbar auf
    Lizenzen und Reprints

Abstract

Objective This study aimed to evaluate the outcomes of newborn pulse oximetry screening in a level IV, tertiary care neonatal intensive care unit (NICU).

Study Design This is a retrospective cohort study of neonates who received newborn pulse oximetry screening after being admitted to a single-center, level-IV NICU between 2014 and 2021. Neonates with known critical congenital heart disease were excluded from the study.

Results Of the 4,493 neonates who had pulse oximetry screening, there were three positive screens (fail rate of 0.067%, 0.67 per 1,000 screened). The average age of screening was 818 hours. There were no positive screens of newborns who were admitted during their initial birth hospitalization and were screened while off oxygen. There were no new diagnoses of critical congenital heart disease (true positives) and there were no known false negatives.

Conclusion The results bring into question whether pulse oximetry screening with the current AAP-endorsed algorithm should be re-evaluated for a level-IV NICU at a children's hospital. However, the results may not be generalizable to other NICU's where echocardiography and prenatal echocardiograms are not as readily available.

Key Points

  • Pulse oximetry has been shown to be effective in decreasing delayed diagnosis of critical congenital heart disease (CCHD); however, there are limited prior studies on newborn pulse oximetry in the NICU.

  • In our study of over 4,000 neonates admitted to a level IV tertiary care NICU, there were no true positives (no new diagnoses of CCHD).

  • Special considerations may be needed for pulse oximetry screening in the NICU setting.

Keywords

pulse oximetry screening - NICU - newborn CCHD - brief resolved unexplained event

Note

The sponsor had no role in the design and conduct of this study.




Publikationsverlauf

Eingereicht: 01. Juli 2022

Angenommen: 18. August 2022

Artikel online veröffentlicht:
28. Oktober 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Oster ME, Aucott SW, Glidewell J. et al. Lessons learned from newborn screening for critical congenital heart defects. Pediatrics 2016; 137 (05) e20154573-e20154573
    CrossrefPubMedSuche in Google Scholar
  • 2 Mahle WT, Newburger JW, Matherne GP. et al; American Heart Association Congenital Heart Defects Committee of the Council on Cardiovascular Disease in the Young, Council on Cardiovascular Nursing, and Interdisciplinary Council on Quality of Care and Outcomes Research, American Academy of Pediatrics Section on Cardiology And Cardiac Surgery, Committee On Fetus And Newborn. Role of pulse oximetry in examining newborns for congenital heart disease: a scientific statement from the AHA and AAP. Pediatrics 2009; 124 (02) 823-836
    CrossrefPubMedSuche in Google Scholar
  • 3 Plana MN, Zamora J, Suresh G, Fernandez-Pineda L, Thangaratinam S, Ewer AK. Pulse oximetry screening for critical congenital heart defects. Cochrane Database Syst Rev 2018; 3 (03) CD011912
    PubMedSuche in Google Scholar
  • 4 Schwartz BN, Hom LA, Von Kohorn I. et al. Newborn pulse oximetry screening at a community hospital: an 8-year experience. Pediatrics 2021; 148 (03) e2020049847
    CrossrefPubMedSuche in Google Scholar
  • 5 Mahle WT, Martin GR, Beekman III RH, Morrow WR. Section on Cardiology and Cardiac Surgery Executive Committee. Endorsement of Health and Human Services recommendation for pulse oximetry screening for critical congenital heart disease. Pediatrics 2012; 129 (01) 190-192
    CrossrefPubMedSuche in Google Scholar
  • 6 Kemper AR, Mahle WT, Martin GR. et al. Strategies for implementing screening for critical congenital heart disease. Pediatrics 2011; 128 (05) e1259-e1267
    CrossrefPubMedSuche in Google Scholar
  • 7 NewSTEPS. Association of Public Health Laboratories. CCHD Screening Status. Accessed May 31, 2022 at: https://www.newsteps.org/resources/disorders/cchd
    PubMed
  • 8 Van Naarden Braun K, Grazel R, Koppel R. et al. Evaluation of critical congenital heart defects screening using pulse oximetry in the neonatal intensive care unit. J Perinatol 2017; 37 (10) 1117-1123
    CrossrefPubMedSuche in Google Scholar
  • 9 Goetz EM, Magnuson KM, Eickhoff JC, Porte MA, Hokanson JS. Pulse oximetry screening for critical congenital heart disease in the neonatal intensive care unit. J Perinatol 2016; 36 (01) 52-56
    CrossrefPubMedSuche in Google Scholar
  • 10 Manja V, Mathew B, Carrion V, Lakshminrusimha S. Critical congenital heart disease screening by pulse oximetry in a neonatal intensive care unit. J Perinatol 2015; 35 (01) 67-71
    CrossrefPubMedSuche in Google Scholar
  • 11 Hom LA, Chan Salcedo C, Revenis M, Martin GR. Quality improvement interventions to improve critical congenital heart disease screening. Pediatr Qual Saf 2019; 4 (05) e221
    CrossrefPubMedSuche in Google Scholar
  • 12 Diller CL, Kelleman MS, Kupke KG, Quary SC, Kochilas LK, Oster ME. A modified algorithm for critical congenital heart disease screening using pulse oximetry. Pediatrics 2018; 141 (05) e20174065
    CrossrefPubMedSuche in Google Scholar